| Luis A Rodriguez-escola, MD | |
|
Km 1 Pr-129, Hospital Pavia Arecibo, Arecibo, PR 00614 | |
| (787) 300-2000 | |
| Not Available |
| Full Name | Luis A Rodriguez-escola |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 18 Years |
| Location | Km 1 Pr-129, Arecibo, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346442555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 17541 (Puerto Rico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centro Medico Wilma N Vazquez | Vega baja, PR | Hospital |
| Hospital Dr Susoni Inc | Arecibo, PR | Hospital |
| Entity Name | Centro Medico Del Turabo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710107883 PECOS PAC ID: 9335051952 Enrollment ID: O20080212000105 |
News Archive
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
It may seem paradoxical that Congress was willing to tackle a grand bargain when the deficit problem looked big and insoluble -; but quickly lost interest as soon as the problem became more manageable. … But the reason isn't really mysterious. A grand bargain would have required both sides to swallow unpalatable compromises. It would have required Democrats to agree to cuts in future spending on Medicare and Social Security. Likewise, it would have required Republicans to accept increases in tax revenue (Doyle McManus, 6/19).
Oxford Performance Materials, Inc. (OPM) and Eastern Plastics Incorporation (EPI) have come to an agreement which enables EPI to sell machined components produced from OXPEKK® implantable polymer. OPM's OXPEKK-IG products have undergone ISO-10993 biocompatibility testing and are supported by a FDA Masterfile.
In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the Baylor College of Medicine Department of Obstetrics and Gynecology, Houston, Texas partnered with the Maternal-Fetal Unit, CEDIFETAL, Centro de Diagnostico de Ultrasonido e Imagenes, CEDIUL, Barranquilla, Columbia and the Unidad De Fertildad Y Genetica De Cartagena, Cartagena de Indias, Columbia, to create the study, Characterization of brain malformations and volume assessment in fetuses with Zika Virus infection using MRI.
Eisai Inc. (Headquarters: Woodcliff Lake, New Jersey, Chairman and CEO: Hajime Shimizu, "Eisai") today announces the successful completion of its acquisition of the biopharmaceutical company, AkaRx, Inc. (Headquarters: Bridgewater, New Jersey, CEO: Robert E. Desjardins), for approximately $255 million.
› Verified 7 days ago
| Entity Name | Msa Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942695788 PECOS PAC ID: 8426358706 Enrollment ID: O20151119000058 |
News Archive
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
It may seem paradoxical that Congress was willing to tackle a grand bargain when the deficit problem looked big and insoluble -; but quickly lost interest as soon as the problem became more manageable. … But the reason isn't really mysterious. A grand bargain would have required both sides to swallow unpalatable compromises. It would have required Democrats to agree to cuts in future spending on Medicare and Social Security. Likewise, it would have required Republicans to accept increases in tax revenue (Doyle McManus, 6/19).
Oxford Performance Materials, Inc. (OPM) and Eastern Plastics Incorporation (EPI) have come to an agreement which enables EPI to sell machined components produced from OXPEKK® implantable polymer. OPM's OXPEKK-IG products have undergone ISO-10993 biocompatibility testing and are supported by a FDA Masterfile.
In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the Baylor College of Medicine Department of Obstetrics and Gynecology, Houston, Texas partnered with the Maternal-Fetal Unit, CEDIFETAL, Centro de Diagnostico de Ultrasonido e Imagenes, CEDIUL, Barranquilla, Columbia and the Unidad De Fertildad Y Genetica De Cartagena, Cartagena de Indias, Columbia, to create the study, Characterization of brain malformations and volume assessment in fetuses with Zika Virus infection using MRI.
Eisai Inc. (Headquarters: Woodcliff Lake, New Jersey, Chairman and CEO: Hajime Shimizu, "Eisai") today announces the successful completion of its acquisition of the biopharmaceutical company, AkaRx, Inc. (Headquarters: Bridgewater, New Jersey, CEO: Robert E. Desjardins), for approximately $255 million.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Luis A Rodriguez-escola, MD 162 Calle San Jorge, Alexander Ph-2, San Juan, PR 00911-2182 Ph: (787) 525-0400 | Luis A Rodriguez-escola, MD Km 1 Pr-129, Hospital Pavia Arecibo, Arecibo, PR 00614 Ph: (787) 300-2000 |
News Archive
Medtronic, Inc. today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the Octopus® Nuvo Tissue Stabilizer as a Class I recall. FDA classifies a recall as Class I when the agency believes that there is a reasonable probability that use of the recalled product will cause serious adverse health consequences or death. On Sept. 14, 2010, Medtronic proactively and voluntarily recalled the device from the market due to the potential that a component of the device could fracture during use.
It may seem paradoxical that Congress was willing to tackle a grand bargain when the deficit problem looked big and insoluble -; but quickly lost interest as soon as the problem became more manageable. … But the reason isn't really mysterious. A grand bargain would have required both sides to swallow unpalatable compromises. It would have required Democrats to agree to cuts in future spending on Medicare and Social Security. Likewise, it would have required Republicans to accept increases in tax revenue (Doyle McManus, 6/19).
Oxford Performance Materials, Inc. (OPM) and Eastern Plastics Incorporation (EPI) have come to an agreement which enables EPI to sell machined components produced from OXPEKK® implantable polymer. OPM's OXPEKK-IG products have undergone ISO-10993 biocompatibility testing and are supported by a FDA Masterfile.
In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the Baylor College of Medicine Department of Obstetrics and Gynecology, Houston, Texas partnered with the Maternal-Fetal Unit, CEDIFETAL, Centro de Diagnostico de Ultrasonido e Imagenes, CEDIUL, Barranquilla, Columbia and the Unidad De Fertildad Y Genetica De Cartagena, Cartagena de Indias, Columbia, to create the study, Characterization of brain malformations and volume assessment in fetuses with Zika Virus infection using MRI.
Eisai Inc. (Headquarters: Woodcliff Lake, New Jersey, Chairman and CEO: Hajime Shimizu, "Eisai") today announces the successful completion of its acquisition of the biopharmaceutical company, AkaRx, Inc. (Headquarters: Bridgewater, New Jersey, CEO: Robert E. Desjardins), for approximately $255 million.
› Verified 7 days ago
Krystal Del Mar Ortiz-diaz, MD Surgery Medicare: Medicare Enrolled Practice Location: Hospital Pavia Arecibo, Carr 129 Km 1.0 Ave San Luis, Arecibo, PR 00613 Phone: 787-650-7272 | |
Victor E Vivoni, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Condominio Profesional Arecibo Medical Center, Suite 203 Carr #2 Km 80.1, Arecibo, PR 00614 Phone: 787-878-3397 Fax: 787-880-4104 | |
Marcos Devarie Hornedo, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Metropolitan Office Building 153 Calle Jose De Diego, Arecibo, PR 00612 Phone: 787-650-1030 | |
Edwin I Soler, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Ave San Luis #622 Carr 129, Arecibo, PR 00612 Phone: 787-817-1269 Fax: 787-817-1269 | |
Guillermo Rivera Colon, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Carr 129 Km 1.1 Hospital Pavia Arecibo, Instituto De Cirugia Del Norte, Arecibo, PR 00613 Phone: 787-650-7272 Fax: 787-650-7269 | |
Dr. Emilio Eugenio Ramos Escoda, M.D Surgery Medicare: Not Enrolled in Medicare Practice Location: Street #129, Hospital Metropolitano Dr. Cayetano Coll Y Toste, Arecibo, PR 00612 Phone: 787-650-7272 Fax: 787-881-7598 |